From: Trends of adverse drug reactions related-hospitalizations in Spain (2001-2006)
2001 | 2002 | 2003 | 2004 | 2005 | 2006 | TOTAL | |
---|---|---|---|---|---|---|---|
% CI 95% | % CI 95% | % CI 95% | % CI 95% | % CI 95% | % CI 95% | % CI 95% | |
Male | |||||||
≤ 16 | 4.1 (2.9-5.2) | 4 (2.9-5.0) | 3.7 (2.5-4.8) | 3.7 (2.6-4.7) | 2.9 (1.7-4.0) | 3.1 (1.9-4.2) | 3.6 (3.1-4.0) |
17-55 | 25.6 (24.0-25.9) | 24.4 (23.4-25.3) | 23.6 (22.5-24.6) | 22.2 (21.2-23.1) | 19.6 (18.5-20.6) | 19.5 (18.4-20.5) | 22.5 (22.0-22.9) |
56-75 | 45.6 (44.7-46.4) | 45.9 (44.1-45.8) | 44.8 (43.9-45.6) | 44.3 (43.4-45.1) | 43.6 (42.7-44.4) | 42.4 (41.5-43.2) | 44.3 (43.9-44.6) |
> 75 | 24.5 (23.5-25.4) | 26.4 (25.4-27.3) | 27.7 (26.7-28.7) | 29.7 (28.7-30.6) | 33.7 (32.7-34.6) | 34.9 (33.9-35.8) | 29.5 (29.1-29.8) |
Female | |||||||
≤ 16 | 3.4 (31.7-37.6) | 3.6 (2.4-4.7) | 3.1 (1.9-4.2) | 2.9 (1.7-4.0) | 2.3 (1.1-3.4) | 2.4 (1.2-.35) | 3 (2.5-3.4) |
17-55 | 22.8 (21.8-23.8) | 21.6 (20.6-22.6) | 20.8 (19.7-21.8) | 19.5 (18.4-20.5) | 17.2 (16.1-18.2) | 17.2 (16.1-18.2) | 19.9 (19.4-20.3) |
56-75 | 36.8 (35.8-37.7) | 35.8 (34.8-36.7) | 35.5 (34.5-36.4) | 34.8 (33.8-35.7) | 32.7 (31.7-33.6) | 31.7 (30.7-32.6) | 34.6 (34.2-34.9) |
> 75 | 36.8 (35.8-37.7) | 38.8 (37.9-39.6) | 40.5 (39.5-41.4) | 42.6 (41.7-43.4) | 47.6 (46.7-48.4) | 48.5 (47.6-49.3) | 42.5 (42.1-42.8) |
TOTAL | |||||||
≤ 16 | 3.7 (2.9-4.4) | 3.8 (3.0-4.5) | 3.4 (2.5-4.2) | 3.3 (2.5-4.0) | 2.6 (1.8-3.4) | 2.7 (1.9-3.4) | 3.3 (2.9-3.6) |
17-55 | 24.2 (23.5-24.9) | 23 (22.3-23.7) | 22.2 (21.4-22.9) | 20.9 (20.1-21.6) | 18.4 (17.6-19.1) | 18.4 (17.6-19.1) | 21.2 (20.9-21.4) |
56-75 | 41.2 (40.5-41.8) | 40.5 (39.8-41.1) | 40.2 (39.5-40.8) | 39.6 (38.9-40.2) | 38.2 (37.5-38.8) | 37.1 (36.4-37.7) | 39.5 (39.2-39.7) |
> 75 | 30.7 (30.0-31.3) | 32.5 (31.8-33.1) | 34 (33.3-34.6) | 36 (35.3-36.6) | 40.6 (39.9-41.2) | 41.7 (41.0-42.3) | 35.9 (35.6-36.1) |